Sphere Fluidics, a company developing single cell analysis systems underpinned by its patented picodroplet technology, updated its flagship platform, Cyto-Mine, to be compliant with current good manufacturing practice (cGMP) regulations enforced by the FDA. By meeting these legally mandated, quality requirements, the Company now provides a solution to increase efficiency and productivity of cell line characterization and selection within drug manufacture workflows. The latest software updates...